Press release
Irritable Bowel Syndrome - Drug Pipeline Landscape, 2022 | 4D Pharma Plc, AbbVie Inc, Bausch Health Americas, Inc., Biomica
Global Insight Services have recently published a report on Irritable Bowel Syndrome - Drug Pipeline Landscape, 2022. The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration.Irritable bowel syndrome (IBS) is a group of symptoms related to functional gastrointestinal disorder characterized by uncomfortable abdominal pain and changes in the bowel movements. IBS classified into four main types based on the type of bowel movement which includes diarrhoea, constipation, in curtain conditions both are common or neither occurs very often (IBS-D, IBS-C, IBS-M/IBS-A, or IBS-U, respectively). IBS previously referred as spastic or nervous colon and spastic bowel.
View Detailed Report Description : https://www.globalinsightservices.com/reports/irritable-bowel-syndrome-drug-pipeline-landscape-2022/
The exact cause of IBS is not known. The cause many be due to combinations of gut-brain axis problems, gut motility disorders, pain sensitivity, infections including small intestinal bacterial overgrowth, neurotransmitters, genetic factors and food sensitivity.
The symptoms of IBS are abdominal pain or discomfort along with cramping or bloating with frequent diarrhoea or constipation and also change in bowel habits. The other symptoms of IBS incudes gastroesophageal reflux relating to genitourinary system, fibromyalgia, headache, backache and along with psychiatric symptoms such as depression and anxiety.
There is no specific laboratory testing or imaging for irritable bowel syndrome. The diagnosis is based on symptoms, performance of specific investigations to rule out organic diseases which present similar symptoms. Basic investigations performed including stool microscopy and culture, blood tests, abdominal ultrasound, endoscopy, biopsies and hydrogen breath testing.
Request Sample Report : https://www.globalinsightservices.com/request-sample/GIS31104
Report Highlights
Global Insight Service's, Irritable Bowel Syndrome - Drug Pipeline Landscape, 2022 report provides an overview of the Irritable Bowel Syndrome pipeline drugs. This report covers detailed insights on Irritable Bowel Syndrome drugs under development, assessment by target, mechanism of action, route of administration and molecule type. Product pipeline by companies, stage of development and key regulatory designations, deals and milestones have been presented to provide insights and thus help industry participants in their decision making. Irritable Bowel Syndrome pipeline report helps gain insights on drugs which are under development stage of drug development process across globally.
Methodology
The research process includes extensive secondary research on public domain and other authentic sources to add or update the pipeline products information. The secondary research sources include, but are not limited to company websites, annual reports, financial reports, company pipeline chart, investor presentations and SEC filings, journals and conferences, and clinical trials registries.
Purchase your copy now : https://www.globalinsightservices.com/checkout/single_user/GIS31104
Scope
The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration. The report provides a review of pipeline therapeutics by companies based on information derived from company and industry-specific sources. The pipeline report covers assessment of therapeutics by mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. Comprehensive profiles of the pipeline products with details such as company overview, development stage; molecule type, target, mechanism of action, route of administration, dosage form, regulatory designations, key deals, clinical trials, and key upcoming milestones are included.
Key Players
4D Pharma Plc
AbbVie Inc
Bausch Health Americas, Inc.
Biomica
Blue Therapeutics Inc
CB2 Therapeutics Inc
ChiRhoClin, Inc
CinRx Pharma LLC
ConSynance Therapeutics Inc
Cosmo Pharmaceuticals NV
Direct Biologics, LLC
Dong-A ST Co Ltd
Emyria Ltd
Request For Customization : https://www.globalinsightservices.com/request-customization/GIS31104
Reasons to buy Irritable Bowel Syndrome Report:
• Develop comprehensive understanding of market landscape - industry structure, value-chain, key players, trends, drivers, and challenges
• Drive revenue and market-entry strategy by gaining insights into which segments and geographies are largest and likely to grow fastest
• Formulate sales and marketing strategies by gaining understanding of competitors, their positioning, and strengths & weaknesses
• Develop business and M&A strategies through understanding of latest trends and emerging players in the market
• Refine your business plans by understanding impact of disruptions such as Covid-19 and Russia-Ukraine conflict on the market
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Irritable Bowel Syndrome - Drug Pipeline Landscape, 2022 | 4D Pharma Plc, AbbVie Inc, Bausch Health Americas, Inc., Biomica here
News-ID: 2796402 • Views: …
More Releases from Global Insight Services
Submersible Pump Market Is Anticipated To Expand From $14.5 Billion In 2024 To $ …
Market Overview
The Submersible Pump Market is anticipated to expand from $14.5 billion in 2024 to $21.8 billion by 2034, registering a steady CAGR of approximately 4.2%. Submersible pumps are designed for submerged operations in various fluids, enabling efficient water extraction, sewage treatment, and oil and gas applications. These pumps are extensively used across sectors such as agriculture, municipal infrastructure, and industrial processes, offering reliable performance in demanding environments. The market's…
Special Mission Aircraft Market Is Anticipated To Expand From $17.3 Billion In 2 …
Market Overview
The Special Mission Aircraft Market is witnessing substantial expansion, driven by the rising need for versatile and technologically advanced aircraft tailored for unique operational roles. These aircraft are not limited to traditional transport duties but are equipped for specific missions such as intelligence gathering, surveillance, reconnaissance, search and rescue, and maritime patrol. As defense and homeland security agencies worldwide focus on enhancing situational awareness and operational efficiency, the Special…
Medical Tourism Market Is Anticipated To Expand From $115.6 Billion In 2024 To $ …
Market Overview
The Medical Tourism Market has emerged as a transformative force within the global healthcare ecosystem, offering patients an affordable and accessible alternative to high-cost treatments in their home countries. It represents a growing trend where individuals travel abroad to receive medical services ranging from elective cosmetic procedures to complex surgeries. The demand surge is primarily fueled by cost-effectiveness, high-quality care, shorter waiting times, and the availability of advanced treatments…
Magnetic Sensor Market Is Anticipated To Expand From $5.42 Billion In 2024 To $1 …
Market Overview
The Magnetic Sensor Market is anticipated to expand from $5.42 billion in 2024 to $12.48 billion by 2034, growing at a CAGR of approximately 8.7%. This rapid growth reflects the rising integration of magnetic sensing technologies across diverse industries such as automotive, consumer electronics, healthcare, and industrial automation. These sensors are essential for detecting magnetic fields and translating them into electrical signals, enabling applications like navigation, position sensing, current…
More Releases for Irritable
Irritable Bowel Syndrome Medication Market Massive Growth opportunity Ahead
Exactitude Consultancy., Ltd. announces the release of the report "Global Irritable Bowel Syndrome Medication Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2034". The report is a detailed and comprehensive analysis presented by region and country, type and application. As the market is constantly changing, the report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets.…
Irritable Bowel Syndrome Treatment Market | $2 Billion by 2026
The market for treating irritable bowel syndrome (IBS) has witnessed significant growth in recent years. In 2018, the estimated value of the IBS treatment market was $1,071 million. However, with increasing awareness and advancements in medical research, the market is projected to reach a staggering $2,012 million by 2026. This represents a remarkable compound annual growth rate (CAGR) of 8.2% during the forecast period from 2019 to 2026.
Irritable bowel syndrome…
Irritable Bowel Syndrome Treatment Market - Industry Trends and Forecast to 2028
The Global Irritable Bowel Syndrome Treatment Market Growth at a rate of 9.32% in the forecast period 2022 to 2028
Global Irritable Bowel Syndrome Treatment Market Size
Irritable bowel syndrome treatment market is segmented on the basis of type, product and end use. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them…
Global Irritable Bowel Syndrome Treatment Market Strategical Analysis Report 202 …
The primary purpose of the statistical analysis is to use data analysis and descriptive statistics. It helps to summarize data from a sample using indexes like mean or standard deviation and inferential statistics. This report includes information and statistics on price levels, location of the product, and demand for the product. The best thing about the statistical analysis report is that it allows businesses to make decisions in terms of…
Irritable Bowel Syndrome (IBS) Treatment Market: Increasing Prevalence of Irrita …
The major factors such as the increasing prevalence of irritable bowel syndrome diseases and rising research & development activities drive the market growth. However, the limited number of product availability and treatment inefficiency restrain the market growth. IBS is a common chronic condition that affects the abdominal organ, large intestine. It is also known as spastic colon, mucous colitis, irritable colon, and spastic colitis. The condition is much different than…
Ayurvedic Cure For Irritable Bowel Syndrome (IBS) Without Operation
The Grocare is a leading natural solution provider for chronic lifestyle diseases – Irritable bowel syndrome (IBS), is a gift of enterprise, and commitment to quality and modern-day buyers’ changing needs. Grocare conforms to stringent quality-related compliances and cost-efficient processes in all aspects of formulation and production. At Grocare, we use natural ingredients developed over the years of research and development. It is FDA certified, safe to use, and affordable…
